{"title":"Serotonin Deficits Modulate Hippocampal Plasticity","authors":"Rocío B. Foltran, Mariano Soiza-Reilly","doi":"10.1021/acschemneuro.6c00120","DOIUrl":null,"url":null,"abstract":"<p>Serotonin (5-HT) modulates a wide variety of functions\r\nacross the\r\ncentral nervous systems. It is a key regulator of neuroplasticity,\r\nparticularly in the hippocampus, where increased serotonergic signaling\r\ngenerally enhances the plasticity processes. However, the consequences\r\nof 5-HT deficiency on brain plasticity remain poorly understood, which\r\nis essential for clarifying the role of 5-HT in the etiology and treatment\r\nof psychiatric disorders. Here, we survey findings from pharmacological\r\nand genetic models of 5-HT depletion, focusing on molecular, cellular,\r\nand neural circuit changes in the hippocampus, alongside related phenotypes.\r\nEvidence indicates that lowering 5-HT levels differentially impacts\r\nthe distinct forms of plasticity. While chronic depletion frequently\r\nincreases molecular plasticity markers, dendritic spines, and neurogenesis,\r\nit simultaneously impairs neural circuit plasticity and hippocampus-dependent\r\nmemory. In contrast, both acute and developmental 5-HT depletion consistently\r\nreduce both the structural and functional neuronal plasticity of the\r\nhippocampus. These findings highlight that the effects of 5-HT deficiency\r\nare highly dependent on the timing, duration, and developmental stages\r\nof the manipulation. Deconstructing this complexity is critical to\r\ninterpreting how reduced 5-HT levels alter hippocampal plasticity\r\nand contribute to psychiatric pathophysiology.</p>","PeriodicalId":13,"journal":{"name":"ACS Chemical Neuroscience","volume":"17 16","pages":"3035–3047"},"PeriodicalIF":4.5000,"publicationDate":"2026-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Chemical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acschemneuro.6c00120","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/8 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Serotonin (5-HT) modulates a wide variety of functions
across the
central nervous systems. It is a key regulator of neuroplasticity,
particularly in the hippocampus, where increased serotonergic signaling
generally enhances the plasticity processes. However, the consequences
of 5-HT deficiency on brain plasticity remain poorly understood, which
is essential for clarifying the role of 5-HT in the etiology and treatment
of psychiatric disorders. Here, we survey findings from pharmacological
and genetic models of 5-HT depletion, focusing on molecular, cellular,
and neural circuit changes in the hippocampus, alongside related phenotypes.
Evidence indicates that lowering 5-HT levels differentially impacts
the distinct forms of plasticity. While chronic depletion frequently
increases molecular plasticity markers, dendritic spines, and neurogenesis,
it simultaneously impairs neural circuit plasticity and hippocampus-dependent
memory. In contrast, both acute and developmental 5-HT depletion consistently
reduce both the structural and functional neuronal plasticity of the
hippocampus. These findings highlight that the effects of 5-HT deficiency
are highly dependent on the timing, duration, and developmental stages
of the manipulation. Deconstructing this complexity is critical to
interpreting how reduced 5-HT levels alter hippocampal plasticity
and contribute to psychiatric pathophysiology.
期刊介绍:
ACS Chemical Neuroscience publishes high-quality research articles and reviews that showcase chemical, quantitative biological, biophysical and bioengineering approaches to the understanding of the nervous system and to the development of new treatments for neurological disorders. Research in the journal focuses on aspects of chemical neurobiology and bio-neurochemistry such as the following:
Neurotransmitters and receptors
Neuropharmaceuticals and therapeutics
Neural development—Plasticity, and degeneration
Chemical, physical, and computational methods in neuroscience
Neuronal diseases—basis, detection, and treatment
Mechanism of aging, learning, memory and behavior
Pain and sensory processing
Neurotoxins
Neuroscience-inspired bioengineering
Development of methods in chemical neurobiology
Neuroimaging agents and technologies
Animal models for central nervous system diseases
Behavioral research